Literature DB >> 31233146

Addressing tobacco smoking and drinking to improve TB treatment outcomes, in South Africa: a feasibility study of the ProLife program.

Goedele M Louwagie1,2, Neo Morojele3, Kamran Siddiqi4, Noreen D Mdege4, John Tumbo2, Olu Omole5, Lerato Pitso1, Max O Bachmann6, Olalekan A Ayo-Yusuf1,2.   

Abstract

Alcohol and tobacco use may lead to negative treatment outcomes in tuberculosis (TB) patients, and even more so if they are HIV-infected. We developed and tested the feasibility of a complex behavioral intervention (ProLife) delivered by lay health workers (LHWs) to improve treatment outcomes in TB patients who smoke tobacco and/or drink alcohol, at nine clinics in South Africa. The intervention comprised three brief motivational interviewing (MI) sessions augmented with a short message service (SMS) program, targeting as appropriate: tobacco smoking, harmful or hazardous drinking and medication adherence. Patients received SMSs twice a week. We measured recruitment and retention rates and assessed fidelity to the MI technique (MI Treatment Integrity 4.1 tool). Finally, we explored LHWs' and patients' experiences through interviews and semi-structured questionnaires, respectively. We screened 137 TB patients and identified 14 smokers, 13 alcohol drinkers, and 18 patients with both behaviors. Participants' mean age was 39.8 years, and 82.2% were men. The fidelity assessments pointed to the LHWs' successful application of key MI skills, but failure to reach MI competency thresholds. Nevertheless, most patients rated the MI sessions as helpful, ascribed positive attributes to their counselors, and reported behavioral changes. SMSs were perceived as reinforcing but difficult language and technical delivery problems were identified as problems. The LHWs' interview responses suggested that they (a) grasped the basic MI spirit but failed to understand specific MI techniques due to insufficient training practice; (b) perceived ProLife as having benefitted the patients (as well as themselves); (c) viewed the SMSs favorably; but (d) considered limited space and privacy at the clinics as key challenges. The ProLife program targeting multiple risk behaviors in TB patients is acceptable but LHW training protocol, and changes in wording and delivery of SMS are necessary to improve the intervention. Trial registration: ISRCTN62728852. © Society of Behavioral Medicine 2019. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Alcohol use; Medication adherence; Motivational Interviewing; Tobacco cessation; Tuberculosis; mHealth

Mesh:

Year:  2020        PMID: 31233146     DOI: 10.1093/tbm/ibz100

Source DB:  PubMed          Journal:  Transl Behav Med        ISSN: 1613-9860            Impact factor:   3.046


  4 in total

Review 1.  Alcohol Use and the Risk of Communicable Diseases.

Authors:  Neo K Morojele; Sheela V Shenoi; Paul A Shuper; Ronald Scott Braithwaite; Jürgen Rehm
Journal:  Nutrients       Date:  2021-09-23       Impact factor: 5.717

2.  Effect of a brief motivational interview and text message intervention targeting tobacco smoking, alcohol use and medication adherence to improve tuberculosis treatment outcomes in adult patients with tuberculosis: a multicentre, randomised controlled trial of the ProLife programme in South Africa.

Authors:  Goedele Louwagie; Mona Kanaan; Neo Keitumetse Morojele; Andre Van Zyl; Andrew Stephen Moriarty; Jinshuo Li; Kamran Siddiqi; Astrid Turner; Noreen Dadirai Mdege; Olufemi Babatunde Omole; John Tumbo; Max Bachmann; Steve Parrott; Olalekan A Ayo-Yusuf
Journal:  BMJ Open       Date:  2022-02-14       Impact factor: 2.692

3.  Risk factors on healthcare-associated infections among tuberculosis hospitalized patients in China from 2001 to 2020: a systematic review and meta-analysis.

Authors:  Xinliang Liu; Nili Ren; Zheng Feei Ma; Meiling Zhong; Hao Li
Journal:  BMC Infect Dis       Date:  2022-04-20       Impact factor: 3.667

4.  Cigarette smoking is associated with an increase in blood monocytes in people with tuberculosis: A cross-sectional study.

Authors:  Joseph Baruch Baluku; Martin Nabwana; Grace Kansiime; Edwin Nuwagira
Journal:  Medicine (Baltimore)       Date:  2022-09-16       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.